1. Home
  2. CVE vs ONC Comparison

CVE vs ONC Comparison

Compare CVE & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cenovus Energy Inc

CVE

Cenovus Energy Inc

HOLD

Current Price

$15.84

Market Cap

34.6B

Sector

Energy

ML Signal

HOLD

ONC

BeiGene Ltd. American Depositary Shares

HOLD

Current Price

$334.18

Market Cap

34.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CVE
ONC
Founded
2009
2010
Country
Canada
Switzerland
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.6B
34.8B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CVE
ONC
Price
$15.84
$334.18
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
12
Target Price
$26.00
$369.50
AVG Volume (30 Days)
11.1M
261.5K
Earning Date
02-19-2026
02-26-2026
Dividend Yield
3.46%
N/A
EPS Growth
N/A
N/A
EPS
1.23
0.58
Revenue
$37,063,946,178.00
$4,972,687,000.00
Revenue This Year
N/A
$895.40
Revenue Next Year
N/A
$22.04
P/E Ratio
$13.19
$547.88
Revenue Growth
N/A
50.43
52 Week Low
$10.23
$172.67
52 Week High
$18.75
$385.22

Technical Indicators

Market Signals
Indicator
CVE
ONC
Relative Strength Index (RSI) 34.85 60.11
Support Level $15.81 $302.14
Resistance Level $17.59 $310.88
Average True Range (ATR) 0.43 6.86
MACD -0.08 2.66
Stochastic Oscillator 12.01 92.34

Price Performance

Historical Comparison
CVE
ONC

About CVE Cenovus Energy Inc

Cenovus Energy Inc is an integrated oil company, focused on creating value through the development of its oil sands assets. The company also engages in production of conventional crude oil, natural gas liquids, and natural gas in Alberta, Canada, with refining operations in the U.S. Net upstream production averaged 786 thousand barrels of oil equivalent per day in 2022. The company had upstream projects across Western Canada; crude oil production and natural gas and NGLs production offshore China and Indonesia. The downstream operations include upgrading and refining operations in Canada and the U.S., and commercial fuel operations across Canada.

About ONC BeiGene Ltd. American Depositary Shares

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.

Share on Social Networks: